NIKKEI 225
38,302.70 +28.65 (+0.07%) HANG SENG
18,171.24 +408.21 (+2.30%) CRUDE OIL
79.46 +0.46 (+0.58%) GOLD FUTURES
2,323.90 +12.90 (+0.56%) DOW
37,903.29 +87.37 (+0.23%) Bitcoin GBP
45,675.74 -2,289.57 (-4.77%)
DarioHealth Corp. (DRIO)
- PR Newswire
Dario Publishes New Peer-Reviewed Study that Deepens the Body of Evidence that Managing Cardiometabolic Conditions in One Integrated Platform Improves Clinical Outcomes
DarioHealth Corp. (Nasdaq: DRIO) ("Dario" or the "Company"), a leader in the global digital health market, announced today new research published in the leading peer-reviewed journal for digital health and medicine, Journal of Internet Medicine (JMIR) demonstrating a clinically significant reduction in blood glucose levels for members using Dario to manage weight alongside diabetes.
- PR Newswire
Dario Signs Two Employers for Cardiometabolic Suite with Integrated GLP-1 Solution
DarioHealth Corp. (Nasdaq: DRIO) ("Dario" or the "Company"), a leader in the global digital health market, announced today two new contracts to provide integrated chronic condition management solutions for two employers beginning in the second quarter of 2024.
- PR Newswire
Dario Publishes Two New Peer-Reviewed Studies Demonstrating Impact of Digital Behavioral Health
DarioHealth Corp. (Nasdaq: DRIO) ("Dario" or the "Company"), a leader in the global digital health market, announced today two new studies published in the leading peer-reviewed journal for digital health and medicine, Journal of Internet Medicine (JMIR), including a Randomized Controlled Trial (RCT) demonstrating the impact of a digital stress reduction program for teens.
